InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: CallMeCrazy post# 141557

Tuesday, 03/08/2016 2:48:18 PM

Tuesday, March 08, 2016 2:48:18 PM

Post# of 403159
As you note Sonis was part of the original animal research for B-OM presented at ASCO 2012. How could this not be viewed as favorable for B-OM?

Side note for P- company after company keeps rolling out new and better -umabs like ike...and of course they will have a large share of the market . But P could really nab some patients and some dollars if it works.

They have not mentioned any benfit for the arthritis part of psoriasis, and of course that is not part of the trial. Would be awfully nice if it had benefit for psoriatic arthritis also- it is a serious problem and certainly drives many patients to all the -imabs, -umabs
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News